RBC Capital Maintains Outperform on NOV, Lowers Price Target to $18
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
RBC Capital analyst Keith Mackey maintains NOV (NYSE:NOV) with a Outperform and lowers the price target from $19 to $18.
RBC Capital analyst Keith Mackey maintains NOV (NYSE:NOV) with a Outperform and lowers the price target from $19 to $18.